Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5TE2

Crystal structure of 7,8-diaminopelargonic acid synthase (BioA) from Mycobacterium tuberculosis, complexed with a mechanism-based inhibitor

5TE2 の概要
エントリーDOI10.2210/pdb5te2/pdb
関連するPDBエントリー3TFT 3TFU 4CXQ
分子名称Adenosylmethionine-8-amino-7-oxononanoate aminotransferase, [5-hydroxy-4-({[6-(3-hydroxypropyl)-4-oxo-1,4-dihydropyridin-3-yl]amino}methyl)-6-methylpyridin-3-yl]methyl dihydrogen phosphate, DI(HYDROXYETHYL)ETHER, ... (6 entities in total)
機能のキーワードinhibitor complex, transaminase, plp, transferase, transferase-inhibitor complex, mechanism-based inhibitor, transferase-transferase inhibitor complex, transferase/transferase inhibitor
由来する生物種Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97)
タンパク質・核酸の鎖数2
化学式量合計98190.07
構造登録者
Maize, K.M.,Eiden, C.,Aldrich, C.C.,Finzel, B.C. (登録日: 2016-09-20, 公開日: 2017-05-31, 最終更新日: 2023-10-04)
主引用文献Eiden, C.G.,Maize, K.M.,Finzel, B.C.,Lipscomb, J.D.,Aldrich, C.C.
Rational Optimization of Mechanism-Based Inhibitors through Determination of the Microscopic Rate Constants of Inactivation.
J. Am. Chem. Soc., 139:7132-7135, 2017
Cited by
PubMed Abstract: Mechanism-based inhibitors (MBIs) are widely employed in chemistry, biology, and medicine because of their exquisite specificity and sustained duration of inhibition. Optimization of MBIs is complicated because of time-dependent inhibition resulting from multistep inactivation mechanisms. The global kinetic parameters k and K have been used to characterize MBIs, but they provide far less information than is commonly assumed, as shown by derivation and simulation of these parameters. We illustrate an alternative and more rigorous approach for MBI characterization through determination of the individual microscopic rate constants. Kinetic analysis revealed the rate-limiting step of inactivation of the PLP-dependent enzyme BioA by dihydro-(1,4)-pyridone 1. This knowledge was subsequently applied to rationally design a second-generation inhibitor scaffold with a nearly optimal maximum inactivation rate (0.48 min).
PubMed: 28510452
DOI: 10.1021/jacs.7b00962
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.8 Å)
構造検証レポート
Validation report summary of 5te2
検証レポート(詳細版)ダウンロードをダウンロード

250059

件を2026-03-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon